LegoChem Biosciences, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 12,081.4 million compared to KRW 11,704.34 million a year ago. Net loss was KRW 20,040.83 million compared to KRW 7,813.91 million a year ago. Basic loss per share from continuing operations was KRW 760 compared to KRW 322 a year ago. Diluted loss per share from continuing operations was KRW 760 compared to KRW 322 a year ago. Basic loss per share was KRW 760 compared to KRW 322 a year ago.
For the six months, sales was KRW 0.00028 million compared to KRW 0.00048 million a year ago. Net loss was KRW 37,786.79 million compared to KRW 16,315.97 million a year ago. Basic loss per share from continuing operations was KRW 1,433 compared to KRW 672 a year ago. Diluted loss per share from continuing operations was KRW 1,433 compared to KRW 672 a year ago. Basic loss per share was KRW 1,433 compared to KRW 672 a year ago.